A critical review of the dosage of teicoplanin in Europe and the USA.

[1]  A. Goldstone,et al.  A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter‐related sepsis in patients receiving intensive chemotherapy for haematological malignancies , 1993, European journal of haematology. Supplementum.

[2]  W. Graninger,et al.  The efficacy of teicoplanin in the treatment of endocarditis caused by gram-positive bacteria. , 1993, The Journal of antimicrobial chemotherapy.

[3]  S. McCann,et al.  Coagulase-negative staphylococcal bacteraemia treated with teicoplanin. , 1993, The Journal of antimicrobial chemotherapy.

[4]  Craven Pc.  Treating bone and joint infections with teicoplanin: hospitalization vs outpatient cost issues. , 1993 .

[5]  M. Levison,et al.  Clinical evaluation of teicoplanin in the treatment of gram-positive bacterial intravascular infections. , 1993, The Journal of antimicrobial chemotherapy.

[6]  Fausto,et al.  Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrhea , 1992, Antimicrobial Agents and Chemotherapy.

[7]  F. Mandelli,et al.  Piperacillin plus amikacin vs. piperacillin plus amikacin plus teicoplanin for empirical treatment of febrile episodes in neutropenic patients receiving quinolone prophylaxis. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  D. Shlaes,et al.  Vancomycin resistance in Enterococcus gallinarum , 1992, Antimicrobial Agents and Chemotherapy.

[9]  H. K. Kulmala,et al.  Pharmacokinetics of teicoplanin upon multiple dose intravenous administration to normal healthy male volunteers , 1992, Biopharmaceutics & drug disposition.

[10]  P. Serra,et al.  4-week treatment of streptococcal native valve endocarditis with high-dose teicoplanin , 1992, Antimicrobial Agents and Chemotherapy.

[11]  H. K. Kulmala,et al.  Pharmacokinetics of teicoplanin upon multiple-dose intravenous administration of 3, 12, and 30 milligrams per kilogram of body weight to healthy male volunteers , 1992, Antimicrobial Agents and Chemotherapy.

[12]  G. Destro,et al.  Teicoplanin in the treatment of gram-positive bacteremia and endocarditis , 1992 .

[13]  C. Webb,et al.  Teicoplanin vs cephamandole for antimicrobial prophylaxis in prosthetic joint implant surgery: (preliminary results). , 1992, The European journal of surgery. Supplement. : = Acta chirurgica. Supplement.

[14]  E. Mini,et al.  Teicoplanin--its role as systemic therapy of burn infections and as prophylaxis for orthopaedic surgery. Italian Study Groups for Antimicrobial Prophylaxis in Orthopaedic Surgery and Burns. , 1992, The European journal of surgery. Supplement. : = Acta chirurgica. Supplement.

[15]  J. Lefrock,et al.  Teicoplanin in the treatment of bone and joint infections. Teicoplanin Bone and Joint Cooperative Study Group, USA. , 1992, The European journal of surgery. Supplement. : = Acta chirurgica. Supplement.

[16]  D. Reece,et al.  Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity , 1991, Antimicrobial Agents and Chemotherapy.

[17]  B. R. Reddy,et al.  Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. , 1991, Annals of internal medicine.

[18]  C. C. Smith,et al.  An open study of teicoplanin in the treatment of gram-positive infections. , 1991, Journal of chemotherapy.

[19]  R. Mccabe,et al.  Intravenous or Intramuscular Teicoplanin Once Daily for Skin and Soft-Tissue Infections , 1991, DICP : the annals of pharmacotherapy.

[20]  G. Fillet,et al.  Allergic cross-reaction of teicoplanin and vancomycin. , 1991, The Journal of antimicrobial chemotherapy.

[21]  A. Goldstone,et al.  A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter-related sepsis in patients receiving intensive chemotherapy for haematological malignancies. , 1991, The Journal of antimicrobial chemotherapy.

[22]  G. Kaatz,et al.  Comparative effect of protein binding on the killing activities of teicoplanin and vancomycin , 1991, Antimicrobial Agents and Chemotherapy.

[23]  D. Levine,et al.  Teicoplanin pharmacokinetics in intravenous drug abusers being treated for bacterial endocarditis , 1991, Antimicrobial Agents and Chemotherapy.

[24]  I. Nováková,et al.  Ceftazidime as monotherapy or combined with teicoplanin for initial empiric treatment of presumed bacteremia in febrile granulocytopenic patients , 1991, Antimicrobial Agents and Chemotherapy.

[25]  F. Meunier,et al.  Randomized study of vancomycin versus teicoplanin for the treatment of gram-positive bacterial infections in immunocompromised hosts , 1991, Antimicrobial Agents and Chemotherapy.

[26]  C. A. Wood,et al.  Failure of treatment with teicoplanin at 6 milligrams/kilogram/day in patients with Staphylococcus aureus intravascular infection. The Infectious Diseases Consortium of Oregon , 1991, Antimicrobial Agents and Chemotherapy.

[27]  A. Sanduzzi,et al.  Efficacy and safety of teicoplanin in gram-positive pulmonary infections. , 1991, Journal of chemotherapy.

[28]  P. Davey,et al.  Teicoplanin monotherapy of serious infections caused by gram-positive bacteria: a re-evaluation of patients with endocarditis or Staphylococcus aureus bacteraemia from a European open trial. , 1991, Journal of Antimicrobial Chemotherapy.

[29]  Y. Drabu,et al.  The post-antibiotic effect of teicoplanin: monotherapy and combination studies. , 1991, The Journal of antimicrobial chemotherapy.

[30]  P. Davey,et al.  A review of the safety profile of teicoplanin. , 1991, The Journal of antimicrobial chemotherapy.

[31]  S. Amadori,et al.  Teicoplanin in the treatment of Gram‐positive bacteraemia in neutropenic patients , 1990, British journal of haematology.

[32]  G. Schaison,et al.  Prevention of Gram‐positive and Candida albicans infections using teicoplanin and fluconazole: a randomized study in neutropenic children , 1990, British journal of haematology.

[33]  F. Meunier,et al.  Ceftazidime plus teicoplanin versus ceftazidime plus amikacin as empiric therapy for fever in cancer patients with granulocytopenia , 1990, British journal of haematology.

[34]  P. Cony-Makhoul,et al.  A prospective study comparing vancomycin and teicoplanin as second‐line empiric therapy for infection in neutropenic patients , 1990, British journal of haematology.

[35]  M. Gore,et al.  Teicoplanin compared to flucloxacillin for antibiotic treatment of neutropenic patients , 1990, British journal of haematology.

[36]  R. Greenberg.  Treatment of bone, joint, and vascular-access-associated gram-positive bacterial infections with teicoplanin , 1990, Antimicrobial Agents and Chemotherapy.

[37]  R. Quintiliani,et al.  Teicoplanin pharmacokinetics in healthy volunteers after administration of intravenous loading and maintenance doses , 1990, Antimicrobial Agents and Chemotherapy.

[38]  C. Launo,et al.  [Antibiotic therapy with teicoplanin in intensive care]. , 1990, Minerva anestesiologica.

[39]  S. Trottier,et al.  Concentrations of teicoplanin in serum and atrial appendages of patients undergoing cardiac surgery , 1990, Antimicrobial Agents and Chemotherapy.

[40]  R. N. Brogden,et al.  Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential. , 1990, Drugs.

[41]  N. Woodford,et al.  Resistance to vancomycin and teicoplanin: an emerging clinical problem , 1990, Clinical Microbiology Reviews.

[42]  D. Espinouse,et al.  [The use of teicoplanin in neutropenic patients: values and limits]. , 1990, Pathologie-biologie.

[43]  P. Small,et al.  Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users , 1990, Antimicrobial Agents and Chemotherapy.

[44]  M. Rybak,et al.  Vancomycin pharmacokinetics in burn patients and intravenous drug abusers , 1990, Antimicrobial Agents and Chemotherapy.

[45]  F. Goldstein,et al.  Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci , 1990, Antimicrobial Agents and Chemotherapy.

[46]  H. Chambers,et al.  Effects of dosage, peak and trough concentrations in serum, protein binding, and bactericidal rate on efficacy of teicoplanin in a rabbit model of endocarditis , 1990, Antimicrobial Agents and Chemotherapy.

[47]  A. Goldstone,et al.  Ceftazidime monotherapy is as effective as ceftazidime combined with gentamicin in the treatment of febrile neutropenic patients. , 1990, The Journal of hospital infection.

[48]  M. Rowland.  Clinical Pharmacokinetics of Teicoplanin , 1990, Clinical pharmacokinetics.

[49]  P. Marone,et al.  Treatment of bone and soft tissue infections with teicoplanin. , 1990, The Journal of antimicrobial chemotherapy.

[50]  C. Watanakunakorn.  In-vitro selection of resistance of Staphylococcus aureus to teicoplanin and vancomycin. , 1990, The Journal of antimicrobial chemotherapy.

[51]  B. Schaaf,et al.  Comparison of efficacy and safety of teicoplanin in gram-positive infections: a multicentre study. , 1990, Scandinavian journal of infectious diseases. Supplementum.

[52]  A. Williams,et al.  Spanish experience with teicoplanin. , 1990, Scandinavian journal of infectious diseases. Supplementum.

[53]  R. Kester,et al.  A comparison of teicoplanin vs. cephradine and metronidazole in surgical prophylaxis: an interim analysis. , 1990, Scandinavian journal of infectious diseases. Supplementum.

[54]  C. Santini,et al.  Teicoplanin in the treatment of gram-positive-bacterial endocarditis , 1989, Antimicrobial Agents and Chemotherapy.

[55]  J. Cheesbrough,et al.  Randomized prospective study comparing vancomycin with teicoplanin in the treatment of infections associated with Hickman catheters , 1989, Antimicrobial Agents and Chemotherapy.

[56]  D. Santoro,et al.  Treatment of Clostridium difficile-associated disease with teicoplanin , 1989, Antimicrobial Agents and Chemotherapy.

[57]  W. Hop,et al.  The efficacy of the combination of teicoplanin or flucloxacillin with netilmicin in the treatment of Staphylococcus aureus bacteraemia. , 1989, The Journal of antimicrobial chemotherapy.

[58]  P. Massip,et al.  Evaluation of teicoplanin for treatment of endocarditis caused by gram-positive cocci in 20 patients , 1989, Antimicrobial Agents and Chemotherapy.

[59]  J. Williams,et al.  Pharmacokinetics of teicoplanin in subjects with varying degrees of renal function. , 1989, The Journal of antimicrobial chemotherapy.

[60]  M. Kenny,et al.  Comparison of the agar dilution, tube dilution, and broth microdilution susceptibility tests for determination of teicoplanin MICs , 1989, Journal of clinical microbiology.

[61]  D. Felmingham,et al.  The bactericidal activity of vancomycin and teicoplanin against methicillin-resistant strains of coagulase negative Staphylococcus spp. , 1989, The Journal of antimicrobial chemotherapy.

[62]  J J Pocidalo,et al.  Evaluation of antibiotic diffusion into cardiac vegetations by quantitative autoradiography. , 1989, The Journal of infectious diseases.

[63]  J. Cheesbrough,et al.  Teicoplanin administration in patients experiencing reactions to vancomycin. , 1989, The Journal of antimicrobial chemotherapy.

[64]  T. Treasure,et al.  Serum and tissue levels of teicoplanin during cardiac surgery: the effect of a high dose regimen. , 1989, The Journal of antimicrobial chemotherapy.

[65]  J. Duval,et al.  Transferable vancomycin and teicoplanin resistance in Enterococcus faecium , 1989, Antimicrobial Agents and Chemotherapy.

[66]  R. Quintiliani,et al.  Pharmacokinetics of single- and multiple-dose teicoplanin in healthy volunteers , 1989, Antimicrobial Agents and Chemotherapy.

[67]  D. Santoro,et al.  Teicoplanin in the treatment of infections by staphylococci, Clostridium difficile and other gram-positive bacteria. , 1989, Journal of Antimicrobial Chemotherapy.

[68]  M. Synott,et al.  Therapy of serious gram-positive infections with teicoplanin. , 1989, Drugs under experimental and clinical research.

[69]  R. T. Miller,et al.  Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. , 1988, Annals of internal medicine.

[70]  C. Watanakunakorn.  In-vitro induction of resistance in coagulase-negative staphylococci to vancomycin and teicoplanin. , 1988, The Journal of antimicrobial chemotherapy.

[71]  A. Bernareggi,et al.  Pharmacokinetics of teicoplanin in pediatric patients , 1988, Antimicrobial Agents and Chemotherapy.

[72]  T. Treasure,et al.  Contamination of blood during cardiopulmonary bypass: the effect of antibiotic prophylaxis. , 1988, The Journal of hospital infection.

[73]  M. Meignier,et al.  [Efficacy of teicoplanin in 25 cases of severe infections caused by gram-positive cocci]. , 1988, Pathologie-biologie.

[74]  P. Benfield,et al.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. , 1988, Drugs.

[75]  T. Treasure,et al.  Antibiotic prophylaxis in cardiac surgery: serum and tissue levels of teicoplanin, flucloxacillin and tobramycin. , 1988, The Journal of antimicrobial chemotherapy.

[76]  D. Ross,et al.  Antibiotic prophylaxis in cardiac surgery: a prospective comparison of two dosage regimens of teicoplanin with a combination of flucloxacillin and tobramycin. , 1988, The Journal of antimicrobial chemotherapy.

[77]  N. Clumeck,et al.  Teicoplanin compared with vancomycin in methicillin-resistant Staphylococcus aureus infections: preliminary results. , 1988, The Journal of antimicrobial chemotherapy.

[78]  F. Parenti,et al.  A multicentre open clinical trial of teicoplanin in infections caused by gram-positive bacteria. , 1988, The Journal of antimicrobial chemotherapy.

[79]  H. Dieterich,et al.  Clinical efficacy and safety of teicoplanin. , 1988, The Journal of antimicrobial chemotherapy.

[80]  J. Hamilton-miller,et al.  Efficacy and safety of teicoplanin in gram-positive peritonitis in patients on peritoneal dialysis. , 1988, The Journal of antimicrobial chemotherapy.

[81]  A. Karchmer.  Antibiotic therapy of nonenterococcal streptococcal and staphylococcal endocarditis: current regimens and some future considerations. , 1988, The Journal of antimicrobial chemotherapy.

[82]  A. Salvadeo,et al.  Pharmacokinetics of teicoplanin in the elderly. , 1988, The Journal of antimicrobial chemotherapy.

[83]  L. Klenerman,et al.  A comparison of teicoplanin and cefuroxime as prophylaxis for orthopaedic implant surgery: a preliminary report. , 1988, The Journal of antimicrobial chemotherapy.

[84]  P. Reinert,et al.  Teicoplanin in combination therapy for febrile episodes in neutropenic and non-neutropenic paediatric patients. , 1988, The Journal of antimicrobial chemotherapy.

[85]  A. Tarral,et al.  Pharmacokinetics of teicoplanin in children. , 1988, The Journal of antimicrobial chemotherapy.

[86]  S. Mehtar,et al.  Teicoplanin in infections caused by methicillin-resistant staphylococci. , 1988, The Journal of antimicrobial chemotherapy.

[87]  G. Taylor,et al.  Teicoplanin in the treatment of skin and soft tissue infections. , 1988, The Journal of antimicrobial chemotherapy.

[88]  S. Pauluzzi,et al.  Teicoplanin in empirical combined antibiotic therapy of bacteraemias in bone marrow transplant patients. , 1988, The Journal of antimicrobial chemotherapy.

[89]  C. Regamey,et al.  Teicoplanin, a new antibiotic effective against gram-positive bacterial infections of the skin and soft tissues. , 1988, Dermatologica.

[90]  A. Wilson,et al.  The effect of medium and inoculum on the activity of vancomycin and teicoplanin against coagulase-negative staphylococci. , 1987, The Journal of antimicrobial chemotherapy.

[91]  S. Pauluzzi,et al.  Treatment of infections by staphylococci and other gram-positive bacteria with teicoplanin: an open study. , 1987, The Journal of antimicrobial chemotherapy.

[92]  A L Barry,et al.  Quality control limits for teicoplanin susceptibility tests and confirmation of disk diffusion interpretive criteria , 1987, Journal of clinical microbiology.

[93]  P. Zech,et al.  Pharmacokinetics of teicoplanin in renal failure , 1987, Antimicrobial Agents and Chemotherapy.

[94]  L. Saravolatz,et al.  In-vitro susceptibility of gram-positive cocci to LY146032 teicoplanin, sodium fusidate, vancomycin, and rifampicin. , 1987, The Journal of antimicrobial chemotherapy.

[95]  T. Treasure,et al.  The use of a new glycopeptide antibiotic, teicoplanin, in the treatment of bacterial endocarditis. , 1987, Postgraduate medical journal.

[96]  M. Wolff,et al.  Poor penetration of teicoplanin into cerebrospinal fluid in patients with bacterial meningitis. , 1987, The Journal of antimicrobial chemotherapy.

[97]  D. Shanson,et al.  Comparison of intravenous teicoplanin with intramuscular amoxycillin for the prophylaxis of streptococcal bacteraemia in dental patients. , 1987, The Journal of antimicrobial chemotherapy.

[98]  A. Goldstone,et al.  Use of teicoplanin for Hickman catheter associated staphylococcal infection in immunosuppressed patients. , 1987, The Journal of hospital infection.

[99]  Favero,et al.  Prospective randomized clinical trial of teicoplanin for empiric combined antibiotic therapy in febrile, granulocytopenic acute leukemia patients , 1987, Antimicrobial Agents and Chemotherapy.

[100]  A. Tarral,et al.  [Treatment of septicemias and skin infections in burn patient by teicoplanin. Study of its skin diffusion]. , 1987, Pathologie-biologie.

[101]  C. Chippaux,et al.  [Teicoplanin and Gram-positive coccus infections. Results of a multicenter study on 66 cases]. , 1987, Pathologie-biologie.

[102]  C. Watanakunakorn.  In-vitro activity of teicoplanin alone and in combination with rifampicin, gentamicin or tobramycin against coagulase-negative staphylococci. , 1987, The Journal of antimicrobial chemotherapy.

[103]  R. Brummett,et al.  Absence of ototoxicity of teichomycin A2 in guinea pigs , 1987, Antimicrobial Agents and Chemotherapy.

[104]  R. Auckenthaler,et al.  Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections. , 1987, The Journal of infectious diseases.

[105]  B. D. de Pauw,et al.  Teicoplanin for therapy of gram-positive infections in neutropenic patients. , 1987, International journal of clinical pharmacology research.

[106]  J. Maskell,et al.  Teicoplanin as a prophylactic antibiotic for dental bacteraemia. , 1986, The Journal of antimicrobial chemotherapy.

[107]  R. Grüneberg,et al.  Teicoplanin in the treatment of infection caused by gram-positive organisms. , 1986, The Journal of hospital infection.

[108]  E. Debbia,et al.  In vitro interactions between teicoplanin and other antibiotics against enterococci and staphylococci. , 1986, The Journal of hospital infection.

[109]  D. Shanson,et al.  Activity of teicoplanin compared with vancomycin alone, and combined with gentamicin, against penicillin tolerant viridans streptococci and enterococci causing endocarditis. , 1986, The Journal of hospital infection.

[110]  C. Mcnulty,et al.  Teicoplanin, its pharmacokinetics, blister and peritoneal fluid penetration. , 1986, The Journal of hospital infection.

[111]  J. Thys,et al.  Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria , 1986, Antimicrobial Agents and Chemotherapy.

[112]  J. Verhaegen,et al.  In vitro activity and human pharmacokinetics of teicoplanin , 1984, Antimicrobial Agents and Chemotherapy.

[113]  C. Tuazon,et al.  Comparative in vitro activities of teichomycin and vancomycin alone and in combination with rifampin and aminoglycosides against staphylococci and enterococci , 1984, Antimicrobial Agents and Chemotherapy.

[114]  H. Neu,et al.  In vitro activity of teichomycin compared with those of other antibiotics , 1983, Antimicrobial Agents and Chemotherapy.

[115]  G. Bodey,et al.  Comparative in vitro study of teichomycin A2 , 1983, Antimicrobial Agents and Chemotherapy.

[116]  P. Varaldo,et al.  In vitro activity of teichomycin and vancomycin alone and in combination with rifampin , 1983, Antimicrobial Agents and Chemotherapy.

[117]  W. Wilson,et al.  Vancomycin therapy for infective endocarditis. , 1981, Reviews of infectious diseases.

[118]  G. M. Findlay.  Recent advances in chemotherapy , 1939 .